Citation Impact
Citing Papers
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor–Prolyl Hydroxylase Inhibitor for Anemia
2017
Hallmarks of Cancer: The Next Generation
2011 Standout
Osteoporosis
2019 Standout
Lipid nanoparticles for mRNA delivery
2021 Standout
Berberine Inhibits Proliferation and Down-Regulates Epidermal Growth Factor Receptor through Activation of Cbl in Colon Tumor Cells
2013
Comparative responses of three rat strains (DA/Han, Sprague-Dawley and Wistar) to treatment with environmental estrogens
2004
Marine natural products
1990 Standout
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Genetic and host factors for dementia in Down's syndrome
2002
Alzheimer's disease in Down syndrome: Neurobiology and risk
2007
Human exposure to bisphenol A (BPA)
2007 Standout
Ds-echinoside A, a new triterpene glycoside derived from sea cucumber, exhibits antimetastatic activity via the inhibition of NF-κB-dependent MMP-9 and VEGF expressions
2011
Down Syndrome: Advances in Molecular Biology and the Neurosciences
2001
Multi-targeted therapy of cancer by genistein
2008 Standout
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
The intestinal epithelial barrier: a therapeutic target?
2016 Standout
ZD6474 – a novel inhibitor of VEGFR and EGFR tyrosine kinase activity
2005
Epidermal growth factor receptor inhibits colitis-associated cancer in mice
2012
The natural polyamines spermidine and spermine prevent bone loss through preferential disruption of osteoclastic activation in ovariectomized mice
2012
Down's syndrome
2003 Standout
Health Supervision for Children With Down Syndrome
2011 Standout
Lack of Effects for Low Dose Levels of Bisphenol A and Diethylstilbestrol on the Prostate Gland of CF1 Mice Exposed in Utero
1999
Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline
2017
Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
2012
Clinical advantages and disadvantages of anabolic bone therapies targeting the WNT pathway
2018
Inhibitory Effects of Estrogenic Compounds, 4-Nonylphenol and Genistein, on 7,12-Dimethylbenz[a]anthracene-Induced Ovarian Carcinogenesis in Rats
2002
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Differential Effects of Sulfated Triterpene Glycosides, Holothurin A 1 , and 24‐Dehydroechinoside A, on Antimetastasic Activity via Regulation of the MMP‐9 Signal Pathway
2010
Differing effects of denosumab and alendronate on cortical and trabecular bone
2013
Safety Evaluation of Lipid Nanoparticle–Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey
2017
Nanomaterial Delivery Systems for mRNA Vaccines
2021 StandoutNobel
Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer’s Disease Pathology in Down Syndrome
2017
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Denosumab Rapidly Increases Cortical Bone in Key Locations of the Femur: A 3D Bone Mapping Study in Women With Osteoporosis
2014
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999−2000: A National Reconnaissance
2002 Standout
Structure‐Activity Relationship and Crystallographic Studies on 4‐Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors
2019 StandoutNobel
Sustained Modeling-Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With Denosumab
2015
The nature of the phenolase enzyme in Mycobacterium leprae: structure-activity relationships of substrates and comparison with other copper proteins and enzymes.
1972
High-Value Components and Bioactives from Sea Cucumbers for Functional Foods—A Review
2011 Standout
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy
2009
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
2017
Spermidine in health and disease
2018 StandoutScience
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
An Extensive New Literature Concerning Low-Dose Effects of Bisphenol A Shows the Need for a New Risk Assessment
2005 Standout
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Preliminary Monitoring of Bisphenol A and Nonylphenol in Human Semen by Sensitive High Performance Liquid Chromatography and Capillary Electrophoresis After Proteinase K Digestion
2003
Reproductive Effects of Long-Term Exposure to Bisphenol A in the Fathead Minnow (Pimephales promelas)
2001
Denosumab Reduces Cortical Porosity of the Proximal Femoral Shaft in Postmenopausal Women With Osteoporosis
2016
Natural variability and the influence of concurrent control values on the detection and interpretation of low-dose or weak endocrine toxicities.
2004
Environmental Exposures and Mammary Gland Development: State of the Science, Public Health Implications, and Research Recommendations
2011
Polyphenol oxidases in plants
1979 Standout
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis
2016
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA Study
2017
Works of Ian Pyrah being referenced
The VEGF receptor tyrosine kinase inhibitor ZD6474 significantly reduces intestinal tumor burden in the Min mouse
2004
Effects ofp-nonylphenol (np) and diethylstilboestrol (des) on the alderley park (alpk) rat: comparison of mammary gland and uterus sensitivity following oral gavage or implanted mini-pumps
1999
Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody
2011
Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study
2016
Reproductive toxicity of denosumab in cynomolgus monkeys
2013
Apo E genotypes and risk of dementia in Down syndrome
1999
Comparative Activities ofp-Nonylphenol and Diethylstilbestrol in Noble Rat Mammary Gland and Uterotrophic Assays
1999
Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys
2011
Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period
2014
Dual inhibition of VEGFR and EGFR signaling reduces the incidence and size of intestinal adenomas in ApcMin/+ mice
2008
Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus Monkeys
2016
High Hematocrit Resulting from Administration of Erythropoiesis-stimulating Agents Is Not Fully Predictive of Mortality or Toxicities in Preclinical Species
2013
Dose-related Differences in the Pharmacodynamic and Toxicologic Response to a Novel Hyperglycosylated Analog of Recombinant Human Erythropoietin in Sprague-Dawley Rats with Similarly High Hematocrit
2013